4.0 Article

Microbial contamination of hematopoietic progenitor cell products

Journal

TRANSFUSION AND APHERESIS SCIENCE
Volume 48, Issue 3, Pages 403-406

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.transci.2013.04.026

Keywords

-

Categories

Ask authors/readers for more resources

Introduction: Microbial screening for contamination is a part of hematopoietic progenitor cell (HPC) collection and infusion procedure. We aimed to find out our microbial contamination rates during collection, processing and infusion steps of HPC products. We also evaluated the clinical course of patients who received contaminated HPC products. Patients-methods: We retrospectively analyzed microbial contamination records of HPC grafts between 2010 and 2012. HPC products of autologous donors were evaluated for contamination at three steps: at the end of mobilization, following processing with DMSO and just before stem cell infusion. Grafts of allogeneic donors were assessed only before HPC transplantation (HCT). Microbiological analysis of HPC samples were performed with an automated system (BacT/Alert (R)). Result: During the study period a total of 492 mobilization procedures were performed on 329 (214 autologous and 115 allogeneic) donors. Bacterial contamination has been detected in 103 of 1630 samples (6%). Ninety-seven out of 1162 blood samples (8%) from 265 patients who were treated with HO' were contaminated. Forty-six patients (41 autologous and 5 allogeneic) were transplanted with contaminated HPC products. During HO' 42 patients experienced febrile neutropenic attack and 34 of them had positive blood culture results. In none of these 34 patients the isolated pathogens were the same organisms with those found in the final contaminated stem cell product before stem cell infusion. None of the patients who received contaminated products died because of sepsis within the posttransplant 30 days. There was no significant difference between patients who received contaminated and non-contaminated products in terms of the first day of fever, duration of fever, engraftment kinetics and duration of hospitalization. Conclusion: Our results suggest that microbial contamination of HPC products is an issue to be prevented, although it may not have a major impact on the general success of HCT. (C) 2013 Published by Elsevier Ltd.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.0
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Hematology

Clinical Characteristics and Outcomes of COVID-19 in Turkish Patients with Hematological Malignancies

Sinem Civriz Bozdag, Guldane Cengiz Seval, Ipek Yonal Hindilerden, Fehmi Hindilerden, Neslihan Andic, Mustafa Baydar, Lale Aydin Kaynar, Selami Kocak Toprak, Hasan Sami Goksoy, Berrin Balik Aydin, Ufuk Demirci, Ferda Can, Vildan Ozkocaman, Eren Gunduz, Zeynep Tugba Guven, Zubeyde Nur Ozkurt, Sinan Demircioglu, Meral Beksac, Idris Ince, Umut Yilmaz, Hilal Eroglu Kucukdiler, Elgun Abishov, Boran Yavuz, Unal Atas, Yasa Gul Mutlu, Volkan Bas, Fahir Ozkalemkas, Hava Uskudar Teke, Vildan Gursoy, Serhat Celik, Rafiye Ciftciler, Munci Yagci, Pervin Topcuoglu, Ozcan Ceneli, Hamza Abbasov, Cem Selim, Muhlis Cem Ar, Orhan Kemal Yucel, Sevil Sadri, Canan Albayrak, Ahmet Muzaffer Demir, Nil Guler, Muzaffer Keklik, Hatice Terzi, Ali Dogan, Zeynep Arzu Yegin, Meltem Kurt Yuksel, Sogol Sadri, Irfan Yavasoglu, Huseyin Saffet Bekoz, Tekin Aksu, Senem Maral, Veysel Erol, Leylagul Kaynar, Osman Ilhan, Ali Zahit Bolaman, Omur Gokmen Sevindik, Arzu Akyay, Muhit Ozcan, Gunhan Gurman, Sule Unal Cangul, Yasemin Yavuz, Reyhan Diz Kucukkaya, Guner Hayri Ozsan

Summary: Patients with hematological malignancy infected with SARS-CoV-2 have an increased risk of severe disease and mortality. Active hematological disease, lower life expectancy related to primary hematological disease, neutropenia at diagnosis of SARS-CoV-2, ICU admission, and first-line therapy used for coronavirus disease-2019 treatment were found to be related to higher mortality rates.

TURKISH JOURNAL OF HEMATOLOGY (2022)

Article Hematology

Alpha-1-Antitrypsin Experience for Steroid-Resistant Acute Graft-Versus-Host Disease

Derya Koyun, Guldane Cengiz Seval, Ekin Kircali, Sinem Civriz Bozdag, Selami Kocak Toprak, Pervin Topcuoglu, Muhit Ozcan, Onder Arslan, Taner Demirer, Osman Ilhan, Meral Beksac, Gunhan Gurman, Meltem Kurt Yuksel

Summary: This study evaluated the effectiveness and safety of alpha-1-antitrypsin (AAT) in the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD). Results showed that AAT was an effective and safe treatment option for SR-aGVHD.

INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION (2022)

Article Clinical Neurology

Endonasal endoscopic approach for sellar metastatic pathologies: a national observation

Gokmen Kahilogullari, Eyup Bayatli, Murat Geyik, Burak Cabuk, Suha Beton, Omur Gunaldi, Osman Tanriverdi, Nuri Eralp Cetinalp, Ozgur Tarkan, Ali Erdem Yildirim, Yahya Efe Guner, Ali Nehir, Ethem Goksu, Mahmut Akyuz, Ilkay Isikay, Bulent Duz, Emrah Celtikci, Hayri Kertmen, Ender Koktekir, Mahmut Camlar, Adile Begum Bahcecioglu Mutlu, Cevriye Cansiz Ersoz, Sinem Civriz Bozdag, Mustafa Berker, Savas Ceylan

Summary: This study focuses on sellar metastases, rare lesions that are difficult to diagnose. By retrospectively analyzing clinical and radiographic features, treatment methods, and patient outcomes, the study aims to evaluate and emphasize the key factors in the diagnosis and endonasal endoscopic management of sellar metastases.

BRITISH JOURNAL OF NEUROSURGERY (2023)

Article Oncology

Pretransplant Consolidation Therapies Improve the Outcome of Myeloablative Allogeneic Transplantation in Adults with Ph-negative Acute Lymphoblastic Leukemia

Zehra Narli Ozdemir, Ekin Kircali, Ugur Sahin, Guldane Cengiz Seval, Sinem Civriz Bozdag, Selami Kocak Toprak, Meltem Kurt Yuksel, Pervin Topcuoglu, Onder Arslan, Taner Demirer, Osman Ilhan, Meral Beksac, Gunhan Gurman, Muhit Ozcan

Summary: The benefit of pre-transplant consolidation treatments remains unclear in patients with acute lymphoblastic leukemia (ALL) undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT). In this study, receiving >= 2 consolidation treatments was associated with better overall survival. Consolidation treatments reduced non-relapse mortality and improved survival.

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2022)

Article Dermatology

Allogeneic hematopoietic stem cell transplantation for heavily pretreated patients with mycosis fungoides and Sezary syndrome

Guldane Cengiz Seval, Ugur Sahin, Sinem Civriz Bozdag, Meltem Kurt Yuksel, Pervin Topcuoglu, Bengu Nisa Akay, Hatice Erdi Sanli, Gunhan Gurman, Selami Kocak Toprak, Muhit Ozcan

Summary: This study retrospectively evaluated the outcomes of AHSCT in heavily pretreated patients with MF/SS. The results showed that AHSCT could effectively rescue a portion of these patients and improve progression-free survival.

DERMATOLOGIC THERAPY (2022)

Editorial Material Cardiac & Cardiovascular Systems

Evaluation of left ventricular functions in individuals with iron deficiency anemia by three-dimensional echocardiography and strain imaging method

Cemre Gul Tekin Cebeci, Demet Menekse Gerede Uludag, Turkan Seda Tan, Irem Muge Akbulut Koyuncu, Sinem Civriz Bozdag, Irem Dincer, Eralp Tutar

KARDIOLOGIA POLSKA (2022)

Meeting Abstract Hematology

The Impact of CD34+Cell and Immunefector Cell Dose on Transplant Outcomes

Derya Koyun, Guldane Cengiz, Sinem Civriz Bozdag, Selami Kocak Toprak, Pervin Topcuoglu, Muhit Ozcan, Onder Arslan, Taner Demirer, Osman Ilhan, Gunhan Gurman, Meral Beksac, Meltem Kurt Yuksel

BLOOD (2022)

Meeting Abstract Hematology

Single Center Real World Data That Compares Autologous Stem Cell Transplant in the Era of Anti-CD38 Monoclonal Antibody Based Treatments for AL Amyloidosis

Hulya Yilmaz, Guldane Cengiz, Bulent Karakaya, Gul Yavuz, Merve Aydogan, Sinem Civriz Bozdag, Selami Kocak Toprak, Meltem Kurt Yuksel, Pervin Topcuoglu, Onder Arslan, Muhit Ozcan, Osman Ilhan, Meral Beksac

BLOOD (2022)

Article Medicine, General & Internal

Eltrombopag for the Treatment of Poor Graft Function Following Haematopoietic Cell Transplantation: Real-Life Data

Ekin Kircali, Gueldane Cengiz Seval, Cemaleddin Ozturk, Huelya Yilmaz, Derya Koyun, Sinem Civriz Bozdag, Selami Kocak Toprak, Pervin Topcuoglu, Onder Arslan, Muhit Ozcan, Taner Demirer, Osman Ilhan, Guenhan Gurman, Meral Beksac, Meltem Kurt Yuksel

Summary: This retrospective cross-sectional study presented the experience of using eltrombopag in patients with delayed thrombocyte recovery and poor graft functioning following haematopoietic cell transplantation. The results showed that eltrombopag could provide a rapid and sustained response, which is crucial for reducing non-relapse mortality after transplantation.

BALKAN MEDICAL JOURNAL (2023)

Article Oncology

The level of fatigue, insomnia, depression, anxiety, stress, and the relationship between these symptoms following allogeneic hematopoietic stem cell transplantation: a cross-sectional study

Sumeyye Noyan, Fatma Gundogdu, Sinem Civriz Bozdag

Summary: This study examined the occurrence of fatigue, insomnia, depression, anxiety, and stress symptoms in patients after allogeneic hematopoietic stem cell transplantation (AHSCT) and explored potential relationships among these symptoms. The results showed that fatigue was the most common symptom, followed by insomnia, depression, anxiety, and stress. There were moderate relationships between these symptoms, with insomnia being strongly associated with fatigue.

SUPPORTIVE CARE IN CANCER (2023)

Article Medicine, General & Internal

Allogeneic Hematopoietic Stem Cell Transplantation for Primary Myelofibrosis: A 20-year Experience in a Single Center

Guldane Cengiz Seval, Sinem Civriz Bozdag, Selami Kocak Toprak, Meltem Kurt Yuksel, Pervin Topcuoglu, Onder Arslan, Taner Demirer, Gunhan Gurman, Meral Beksac, Osman Ilhan, Muhit Ozcan

Summary: This study retrospectively analyzed the overall outcome of 26 patients with primary myelofibrosis who underwent allogeneic hematopoietic stem cell transplantation. The results showed that allogeneic hematopoietic stem cell transplantation has a favorable therapeutic effect for patients with primary myelofibrosis.

BALKAN MEDICAL JOURNAL (2023)

Meeting Abstract Biophysics

Allogeneic hematopoietic stem cell transplantation in elderly patients with acute myeloid leukemia: A single center experience

O. Ilhan, G. Yavuz, G. Cengiz Seval, S. Civriz Bozdag, M. Kurt Yuksel, P. Topcuoglu, O. Arslan, M. Ozcan, T. Demirer, G. Gurman, M. Beksac

BONE MARROW TRANSPLANTATION (2022)

Meeting Abstract Biophysics

Prophylactic defibrotide is effective for acute graft versus host disease as well as sinusoidal obstructive syndrome

E. Kircali, G. Cengiz Seval, S. Civriz Bozdag, M. Kurt Yuksel, P. Topcuoglu, O. Arslan, M. Ozcan, T. Demirer, G. Gurman, M. Beksac, O. Ilhan, S. K. Toprak

BONE MARROW TRANSPLANTATION (2022)

Meeting Abstract Biophysics

Use of venetoclax in combination with hypomethylating agents in patients with acute myeloid leukemia relapsing after allogeneic hematopoietic stem cell transplantation

C. Ozturk, U. Sahin, G. C. Seval, S. C. Bozdag, S. K. Toprak, M. K. Yuksel, P. Topcuoglu, M. Ozcan, G. Gurman, O. Ilhan, O. Arslan

BONE MARROW TRANSPLANTATION (2022)

Meeting Abstract Oncology

The efficacy and safety of second allogeneic hematopoietic stem cell transplantation.

Selami Kocak Toprak, Ekin Korcalo, Guldane Cengiz Seval, Sinem Civriz Bozdag, Meltem Kurt Yuksel, Pervin Topcuoglu, Onder Arslan, Muhit Ozcan, Taner Demirer, Gunhan Gurman, Meral Beksac, Osman Ilhan

JOURNAL OF CLINICAL ONCOLOGY (2022)

No Data Available